BIO
$338.77
Revenue | $649.73Mn |
Net Profits | $653.17Mn |
Net Profit Margins | 100.53% |
Bio-rad Laboratories, Inc.’s revenue jumped 2.79% since last year same period to $649.73Mn in the Q3 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 1.76% jump in its revenue since last 3-months.
Bio-rad Laboratories, Inc.’s net profit jumped 514.71% since last year same period to $653.17Mn in the Q3 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 130.16% jump in its net profits since last 3-months.
Bio-rad Laboratories, Inc.’s net profit margin jumped 498.05% since last year same period to 100.53% in the Q3 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 129.64% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.16 |
EPS Estimate Current Year | 1.16 |
Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.16 - a -42.29% fall from last quarter’s estimates.
Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 1.16.
Earning Per Share (EPS) | 2.01 |
Bio-rad Laboratories, Inc.’s earning per share (EPS) fell -13.73% since last year same period to 2.01 in the Q3 2024. This indicates that the Bio-rad Laboratories, Inc. has generated -13.73% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-02 | 2.01 | 3.11 | 54.73% |
2024-05-08 | 2.15 | 2.29 | 6.51% |
2024-10-31 | 1.16 | 2.01 | 73.28% |